Showing results (51-60 of 86) with videos related to
Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|January 1, 1992
Phase II study of Edatrexate in stage III and IV non-small-cell lung cancerR L Souhami, R M Rudd, S G Spiro, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesotheliomaC W Mulatero, R T Penson, D Papamichael, et al.British Journal of Diseases of the Chest|January 1, 1984
Bronchoalveolar lavage in the diagnosis of diffuse pulmonary shadowingP R Studdy, R M Rudd, A R Gellert, et al.Thorax|July 1, 1985
Asbestosis: assessment by bronchoalveolar lavage and measurement of pulmonary epithelial permeabilityA R Gellert, J A Langford, R J Winter, et al.FEBS Letters|September 16, 1999
Human neutrophil elastase regulates the expression and secretion of elafin (elastase-specific inhibitor) in type II alveolar epithelial cellsP T Reid, M E Marsden, G A Cunningham, et al.Lancet (London, England)|April 29, 1995
Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph?P Wilkinson, D M Hansell, J Janssens, et al.Respiratory Medicine|February 1, 1994
Respiratory muscle function in patients with asbestos-related pleural diseaseN A Jarad, M P Carroll, C Laroche, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Phase II study of vinorelbine in patients with malignant pleural mesotheliomaJ P Steele, J Shamash, M T Evans, et al.European Journal of Respiratory Diseases|November 1, 1984
Erythrapheresis compared with placebo apheresis in patients with polycythaemia secondary to hypoxic lung diseaseJ A Wedzicha, F E Cotter, R M Rudd, et al.British Medical Journal (Clinical Research Ed.)|February 12, 1983
Erythrapheresis in patients with polycythaemia secondary to hypoxic lung diseaseJ A Wedzicha, R M Rudd, M C Apps, et al.Pageof 9